Related references
Note: Only part of the references are listed.Prediction of pharmacokinetic studies outcome for locally acting nasal sprays by using different in vitro methods
Nadica Sibinovska et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)
Comparison of Various Cell Lines and Three-Dimensional Mucociliary Tissue Model Systems to Estimate Drug Permeability Using an In Vitro Transport Study to Predict Nasal Drug Absorption in Rats
Tomoyuki Furubayashi et al.
PHARMACEUTICS (2020)
Quantitative estimation of drug permeation through nasal mucosa using in vitro membrane permeability across Calu-3 cell layers for predicting in vivo bioavailability after intranasal administration to rats
Daisuke Inoue et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2020)
Suitability and functional characterization of two Calu-3 cell models for prediction of drug permeability across the airway epithelial barrier
Nadica Sibinovska et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Evaluation of in vitro Penetration of Fluticasone Propionate from MP-AzeFlu and Fluticasone Propionate Nasal Spray Through EpiAirway™606 Tissues Using Vertical Diffusion Cells
William E. Berger et al.
JOURNAL OF ASTHMA AND ALLERGY (2020)
Factors influencing drug deposition in the nasal cavity upon delivery via nasal sprays
Mingyue Gao et al.
JOURNAL OF PHARMACEUTICAL INVESTIGATION (2020)
How to characterize a nasal product. The state of the art of in vitro and ex vivo specific methods
Laurent Salade et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Suitability of RPMI 2650 cell models for nasal drug permeability prediction
Nadica Sibinovska et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2019)
Pharmacological Characterization of the RPMI 2650 Model as a Relevant Tool for Assessing the Permeability of Intranasal Drugs
Clement Mercier et al.
MOLECULAR PHARMACEUTICS (2018)
Enhanced nasal drug delivery efficiency by increasing mechanical loading using hypergravity
Dongjoo Kim et al.
SCIENTIFIC REPORTS (2018)
Development of coated liposomes loaded with ghrelin for nose-to-brain delivery for the treatment of cachexia
Laurent Salade et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Ipratropium is 'luminally recycled' by an inter-play between apical uptake and efflux transporters in Calu-3 bronchial epithelial cell layers
Vijender Panduga et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Application of RPMI 2650 nasal cell model to a 3D printed apparatus for the testing of drug deposition and permeation of nasal products
Michele Pozzoli et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2016)
Application of RPMI 2650 as a cell model to evaluate solid formulations for intranasal delivery of drugs
Vanessa S. S. Goncalves et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
Different types of intranasal steroids for chronic rhinosinusitis
Lee Yee Chong et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2016)
The characterization of the human cell line Calu-3 under different culture conditions and its use as an optimized in vitro model to investigate bronchial epithelial function
Mateja Erdani Kreft et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
The Characterization of the Human Nasal Epithelial Cell Line RPMI 2650 Under Different Culture Conditions and Their Optimization for an Appropriate in vitro Nasal Model
Mateja Erdani Kreft et al.
PHARMACEUTICAL RESEARCH (2015)
A Comparison of the Deposition Patterns of Different Nasal Spray Formulations Using a Nasal Cast
Yu Pu et al.
AEROSOL SCIENCE AND TECHNOLOGY (2014)
Retinoic acid and hydrocortisone strengthen the barrier function of human RPMI 2650 cells, a model for nasal epithelial permeability
Levente Kuerti et al.
CYTOTECHNOLOGY (2013)
Pharmaceutical applications of the Calu-3 lung epithelia cell line
Hui Xin Ong et al.
EXPERT OPINION ON DRUG DELIVERY (2013)
Improved Pharmacokinetics of Sumatriptan With Breath Powered Nasal Delivery of Sumatriptan Powder
Mohammad Obaidi et al.
HEADACHE (2013)
Bioavailability and disposition of azelastine and fluticasone propionate when delivered by MP29-02, a novel aqueous nasal spray
Hartmut Derendorf et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Cultivation of RPMI 2650 cells as an in-vitro model for human transmucosal nasal drug absorption studies: optimization of selected culture conditions
Stephan Reichl et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2012)
Intranasal drug delivery: An efficient and non-invasive route for systemic administration Focus on opioids
Stanislas Grassin-Delyle et al.
PHARMACOLOGY & THERAPEUTICS (2012)
Characterisation of the interactive properties of microcrystalline cellulose-carboxymethyl cellulose hydrogels
G. H. Zhao et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
RPMI 2650 epithelial model and three-dimensional reconstructed human nasal mucosa as in vitro models for nasal permeation studies
Annette Wengst et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2010)
New Generation of Hybrid Poly/Oligosaccharide Nanoparticles as Carriers for the Nasal Delivery of Macromolecules
Desiree Teijeiro-Osorio et al.
BIOMACROMOLECULES (2009)
Dissolution in nasal fluid, retention and anti-inflammatory activity of fluticasone furoate in human nasal tissue ex vivo
D. Baumann et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2009)
Evaluation of human nasal RPMI 2650 cells grown at an air-liquid interface as a model for nasal drug transport studies
Shuhua Bai et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Beneficial effect of antibiotics on ciliary beat frequency of human nasal epithelial cells exposed to bacterial toxins
Roel Mallants et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2008)
Transport characteristics of zolmitriptan in a human intestinal epithelial cell line Caco-2
Lushan Yu et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2007)
Airway selectivity: An update of pharmacokinetic factors affecting local and systemic disposition of inhaled steroids
Staffan Edsbacker et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2006)
The use of human nasal in vitro cell systems during drug discovery and development
S Dimova et al.
TOXICOLOGY IN VITRO (2005)
Effects of preservatives in nasal formulations on the mucosal integrity: An electron microscopic study
E Lebe et al.
PHARMACOLOGY (2004)
Serially passaged human nasal epithelial cell monolayer for in vitro drug transport studies
JW Yoo et al.
PHARMACEUTICAL RESEARCH (2003)
Permeability of porcine nasal mucosa correlated with human nasal absorption
C Wadell et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2003)
Systemic bioavailability of fluticasone propionate administered as nasal drops and aqueous nasal spray formulations
PT Daley-Yates et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2001)
HT29-MTX and Caco-2/TC7 monolayers as predictive models for human intestinal absorption: Role of the mucus layer
C Pontier et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2001)
In situ nasal absorption of midazolam in rats
JC Olivier et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2001)
Share Paper
